Tuesday, October 18, 2022 9:23:58 AM
Not really jammy32. Reading is fundamental. Again my estimate of 2 to 3 years refers to:
(1) How long I believe it will take for the NWBO share price to reach a valuation of $48 per share, and a buyout value of $72 per share.
(2) How long it will take for NWBio to fully complete all of the milestones listed on my list below.
Many current NWBO investors will not wait 2 to 3 years to sell their NWBO shares, and that is ok. But, they will still be able to sell their NWBO shares at $25 to $35 per share or higher in the coming months.
In the next few intervening months, the NWBO share price will begin to rise significantly after each of my milestones listed below are completed. Beginning with milestones 1 & 2 (official DCVax-L top line data release & publication of the journal article), which could happen within the next 30 days or less, the NWBO share price will gradually begin to rise to $3, then $5, then $7, then $11, then $15, then to $20, then to $25, and higher.
The NWBO share price could rise to $25 or higher price per share in less than a year, especially after DCVax-L regulatory approvals in the UK and other countries.
NWBO investors will be significantly wealthier in about 1 year of less. But, in my opinion to realize a more full value of $48 per share, or a buyout value of $72 per share, I believe this will take 2 to 3 years. Again, I hope I am wrong, and all NWBO shareholders get to these values sooner.
(1) How long I believe it will take for the NWBO share price to reach a valuation of $48 per share, and a buyout value of $72 per share.
(2) How long it will take for NWBio to fully complete all of the milestones listed on my list below.
Many current NWBO investors will not wait 2 to 3 years to sell their NWBO shares, and that is ok. But, they will still be able to sell their NWBO shares at $25 to $35 per share or higher in the coming months.
In the next few intervening months, the NWBO share price will begin to rise significantly after each of my milestones listed below are completed. Beginning with milestones 1 & 2 (official DCVax-L top line data release & publication of the journal article), which could happen within the next 30 days or less, the NWBO share price will gradually begin to rise to $3, then $5, then $7, then $11, then $15, then to $20, then to $25, and higher.
The NWBO share price could rise to $25 or higher price per share in less than a year, especially after DCVax-L regulatory approvals in the UK and other countries.
NWBO investors will be significantly wealthier in about 1 year of less. But, in my opinion to realize a more full value of $48 per share, or a buyout value of $72 per share, I believe this will take 2 to 3 years. Again, I hope I am wrong, and all NWBO shareholders get to these values sooner.
Recent NWBO News
- CNS Drug Delivery Breakthroughs Unlock Significant Biotech Market Opportunities • InvestorsHub NewsWire • 05/11/2026 01:00:00 PM
- CNS Drug Delivery Breakthroughs Unlock Significant Biotech Market Opportunities • GlobeNewswire Inc. • 05/11/2026 12:30:00 PM
- Northwest Biotherapeutics Appoints Dr. Annalisa Jenkins As Strategic Adviser To Advance Dendritic Cell Cancer Vaccine Platform • PR Newswire (US) • 04/30/2026 04:38:00 PM
- Northwest Biotherapeutics Appoints Dr. Annalisa Jenkins As Strategic Adviser To Advance Dendritic Cell Cancer Vaccine Platform • PR Newswire (US) • 04/30/2026 04:30:00 PM
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 04/21/2026 04:15:08 AM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 04/16/2026 09:25:30 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/07/2026 04:30:50 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/31/2026 09:04:37 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/15/2026 10:06:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/02/2026 10:14:59 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 11/28/2025 09:43:27 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 11/25/2025 10:23:07 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/20/2025 09:26:03 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 11/19/2025 09:15:48 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2025 09:44:21 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/31/2025 04:29:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2025 08:40:05 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/24/2025 04:28:38 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/14/2025 06:22:26 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2025 09:00:38 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 07/01/2025 09:04:38 PM
